Stephanie Okey
CIK 1742616 · last filed 2026-03-12
Stephanie Okey is a corporate insider who has filed 36 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for PTCT, was dated Mar 12, 2026. Across all open-market trades the lifetime net is −$2.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.06M
4
36
-$2.89M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTCT | Director | 8,000 | $75.14 | $601.1K | -$1.96M | 16 | 2026-03-12 |
| CRNX | Director | 13,300 | $34.47 | $458.5K | -$930.7K | 9 | 2026-03-04 |
| Catalent, Inc. (CTLT) Delisted | Director | 0 | $63.48 | $0 | $0 | 4 | 2024-12-18 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Director | — | $44.15 | — | $0 | 7 | 2023-03-02 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-12 | PTCT | Mixed | — | -$551.6K | EDGAR |
| 2026-03-09 | PTCT | Sell (S) | −6,333 | -$401.4K | EDGAR |
| 2026-03-04 | CRNX | Sell (S) | −3,000 | -$119.0K | EDGAR |
| 2026-01-06 | PTCT | Grant (A) | +4,000 | $0 | EDGAR |
| 2025-11-21 | PTCT | Gift (G) | −867 | $0 | EDGAR |
| 2025-06-13 | CRNX | Grant (A) | +6,900 | $0 | EDGAR |
| 2025-03-17 | PTCT | Sell (S) | −5,000 | -$270.0K | EDGAR |
| 2025-01-07 | PTCT | Grant (A) | +4,000 | $0 | EDGAR |
| 2024-12-18 | Catalent, Inc. (CTLT) Delisted | Disp (D) | −12,635 | $0 | EDGAR |
| 2024-11-01 | Catalent, Inc. (CTLT) Delisted | Grant (A) | +4,663 | $0 | EDGAR |